|
|
|
Hikma Pharmaceuticals (UK): Shares in Issue and Investability Weight Change
Changes in FTSE UK Index Series
23 June 2020
Following the receipt of updated shareholder information for Hikma Pharmaceuticals, (UK, constituent) as a result of a secondary placing and concurrent share repurchase, please see details of affected indexes and effective dates below:
|
Index |
Effective From |
FTSE 100 Index |
26 June 2020 |
FTSE 350 Index |
26 June 2020 |
FTSE All-Share Index |
26 June 2020 |
FTSE 350 Lower Yield Index |
26 June 2020 |
* The change to Index shares reflects the secondary placing only.
|
For further information please contact FTSE Russell Client Services at info@ftserussell.com or call:
Alternatively please visit our website at www.ftserussell.com Terms of Use | Copyright © 2020 FTSE Russell |
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.